Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

IMPORTANCE: Complete metastatic ablation of oligometastatic prostate cancer may provide an alternative to early initiation of androgen deprivation therapy (ADT). OBJECTIVE: To determine if stereotactic ablative radiotherapy (SABR) improves oncologic outcomes in men with oligometastatic prostate canc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Phillips, Ryan, Shi, William Yue, Deek, Matthew, Radwan, Noura, Lim, Su Jin, Antonarakis, Emmanuel S., Rowe, Steven P., Ross, Ashley E., Gorin, Michael A., Deville, Curtiland, Greco, Stephen C., Wang, Hailun, Denmeade, Samuel R., Paller, Channing J., Dipasquale, Shirl, DeWeese, Theodore L., Song, Daniel Y., Wang, Hao, Carducci, Michael A., Pienta, Kenneth J., Pomper, Martin G., Dicker, Adam P., Eisenberger, Mario A., Alizadeh, Ash A., Diehn, Maximilian, Tran, Phuoc T.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7225913/
https://ncbi.nlm.nih.gov/pubmed/32215577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.0147
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars